Nonalcoholic fatty liver disease (NAFLD) is entering a new era in terms of diagnosis and
conceptualization. The term NAFLD is considered to not reflect current knowledge …

The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) has increased rapidly worldwide, making NAFLD/NASH an important global health …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
prevalence in patients with type 2 diabetes mellitus is between 55–80%. The spectrum of …

Introduction: Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). NAFLD …

Non‐alcoholic fatty liver disease (NAFLD) is one of the major causes of liver disease
worldwide. To detect early stages of NAFLD and start treatment or to monitor the changes in …

Non-alcoholic fatty liver disease (NAFLD) is a chronic disease which is currently the most
common hepatic disorder affecting up to 38% of the general population with differences …

Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a
worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is expected to increase because
of the current epidemics of obesity and diabetes, and NAFLD has become a major cause of …

This study investigated the correlation between magnetic resonance elastography (MRE)
and shear wave ultrasound elastography (SWE) in patients with clinically diagnosed or …

Non-alcoholic fatty liver disease (NAFLD) is extremely prevalent in the Western world. Non-
invasive diagnostic methods should be able to reflect the presence and severity of liver fatty …